Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort

BACKGROUND: Safety and efficacy of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction (GEJ) cancer could be demonstrated in predominantly Asian cohorts, whereas data in Western patients outside of clinical trials are vastly missing. METHODS: In this multi-institutional ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlintl, Verena, Huemer, Florian, Rinnerthaler, Gabriel, Melchardt, Thomas, Winder, Thomas, Reimann, Patrick, Riedl, Jakob, Amann, Arno, Eisterer, Wolfgang, Romeder, Franz, Piringer, Gudrun, Ilhan-Mutlu, Aysegül, Wöll, Ewald, Greil, Richard, Weiss, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744304/
https://www.ncbi.nlm.nih.gov/pubmed/35012477
http://dx.doi.org/10.1186/s12885-021-09115-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744304/
https://www.ncbi.nlm.nih.gov/pubmed/35012477
http://dx.doi.org/10.1186/s12885-021-09115-6

Ejemplares similares